Menu
Recruiting NCT07447011

Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea

No phase Interventional Primary Open Angle Glaucoma Obstructive Sleep Apnea Obesity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: lifetyle corrections and CPAP, CPAP.
Who it may be relevant to
Registry conditions: Primary Open Angle Glaucoma, Obstructive Sleep Apnea, Obesity. Basic parameters: 30 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended

Detailed description

forty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved and divided to group I or group II (number of patients will be twenty in every group) for three month. both groups will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.

Interventions

  • Behavioral lifetyle corrections and CPAP
    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.
  • Other CPAP
    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.

Primary outcome measures

  • Intraocular pressure [Time frame: it will be measured after 12 weeks]
Secondary outcome measures (6)
  • apnea hypopnea index [Time frame: It will be measured after 12 weeks]
  • Epowrth sleepiness scale [Time frame: It will be measured after 12 weeks]
  • body mass index [Time frame: It will be measured after 12 weeks]
  • waist circumference [Time frame: it will be measured after 12 weeks]
  • neck circumferfence [Time frame: It will be measured after 12 weeks]
  • glaucoma related quality of life questioanire [Time frame: It will be measured after 12 weeks]

Eligibility criteria

Inclusion criteria

  • Obstructive sleep apnea patients
  • obese patients
  • glaucoma (open angle form with ocular hyoertension)

Exclusion criteria

cardiac patients renal patients hepatic patients

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Giza

Identifiers

NCT: NCT07447011 · IRB000-14233-70

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗